| Particulars |
| Company Name |
Glenmark Pharmaceuticals Ltd |
| Face Value |
1 |
| BSE Code |
532296 |
| Year End |
202503 |
| Full Year |
| Equity (Rs in Cr.) |
28.22 |
| B.V. Rs |
848.30 |
| Sales Rs in Cr. |
9,226.41 |
| NP Rs in Cr. |
1,744.33 |
| NP Var% |
22.00 |
| Div% |
250.00 |
| CPS Rs |
69.60 |
| EPS Rs |
61.80 |
| Traded Value(Rs in Lakhs) |
1,215.11 |
| 52 Week High |
2,372.00 |
| 52 Week Low |
1,340.00 |
| Price BSE |
2,298.00 |
| Price NSE |
2,300.00 |
| Market Capital(Rs in Cr.) |
64,851.16 |
| P/C Ratio |
33.00 |
| P/E Ratio |
37.20 |
| Price Vs.BV |
2.71 |
| Latest Quarter |
| Year End |
202512 |
| Sales Rs in Cr. |
2,328.23 |
| NP Rs in Cr. |
426.20 |
| NP Var % |
3.00 |
| Trailing Twelve Months |
| Year End |
202512 |
| Sales |
8,273.06 |
| OPM |
40.00 |
| NP |
1,895.02 |
| NP Var% |
-35.60 |
| EPS |
52.57 |
| PE |
43.71 |
|